期刊文献+

IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients 被引量:13

IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
下载PDF
导出
摘要 AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P < 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1. AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第31期3636-3639,共4页 世界胃肠病学杂志(英文版)
基金 Supported by The grant OAIC 394/10(to M.V.)from Hospital Clínico Universidad de Chile
关键词 IL28B Hepatitis C virus Chile Pegylated interferon RIBAVIRIN 单核苷酸多态性 聚合酶链反应 丙型肝炎病毒 联合治疗 患者 慢性 智利 限制性片段
  • 相关文献

参考文献1

二级参考文献63

  • 1[1]Global burden of disease (GBD) for hepatitis C.J Clin Pharmacol 2004; 44:20-29
  • 2[2]Shepard CW,Finelli L,Fiore AE,Bell BP.Epidemiology of hepatitis B and hepatitis B virus infection in United States children.Pediatr Infect Dis J 2005; 24:755-760
  • 3[3]Frank C,Mohamed MK,Strickland GT,Lavanchy D,Arthur RR,Magder LS,El Khoby T,Abdel-Wahab Y,Aly Ohn ES,Anwar W,Sallam I.The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.Lancet 2000; 355:887-891
  • 4[4]Perz JF,Armstrong GL,Farrington LA,Hutin YJ,Bell BP.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.J Hepatol 2006; 45:529-538
  • 5[5]Alter MJ,Hutin YJ,Armstrong GL.Epidemiology of hepatitis C.In:Liang TJ,Hoofnagle JH,editors.Hepatitis C.San Diego:Academic Press,2000:169-183
  • 6[6]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 7[7]Armstrong GL,Wasley A,Simard EP,McQuillan GM,Kuhnert WL,Alter MJ.The prevalence of hepatitis C virus infection in the United States,1999 through 2002.Ann Intern Med 2006; 144:705-714
  • 8[8]Law MG,Dore GJ,Bath N,Thompson S,Crofts N,Dolan K,Giles W,Gow P,Kaldor J,Loveday S,Powell E,Spencer J,Wodak A.Modelling hepatitis C virus incidence,prevalence and long-term sequelae in Australia,2001.Int J Epidemiol 2003;32:717-724
  • 9[9]Alter MJ.Prevention of spread of hepatitis C.Hepatology 2002;36:S93-S98
  • 10[10]Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.Centers for Disease Control and Prevention.MMWR Recomm Rep 1998; 47:1-39

共引文献71

同被引文献61

引证文献13

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部